AB006. SOH22ABS118. Neoadjuvant Chemotherapy Prescription in Estrogen Receptor Positive Breast Cancer in the West of Ireland

Amy Graham,Carson McFeetors,Matthew Davey,Ray McLaughlin,Karl Sweeney,Carmel Malone,Michael Barry,Maccon Keane,Aoife Lowery,Michael Kerin

Mesentery and peritoneum（2022）

引用 0|浏览8

暂无评分

摘要

Background: Estrogen receptor positive (ER+) breast cancers is a hormone sensitive disease, response well to endocrine therapies and carry favourable prognoses. Recently, there has been a vogue to prescribe neoadjuvant chemotherapy (NACT) for patients diagnosed with ER+ breast cancer.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要